Dr Reddy's, Hetero ink royalty-free voluntary licencing pacts with Gilead Sciences for HIV drug Lenacapavir
Wednesday, 2 October 2024
Dr Reddy's Laboratories and Hetero, along with other generic drug makers, enter into voluntary licensing agreements with Gilead Sciences to produce and distribute HIV drug Lenacapavir in India and 120 LMICs. Lenacapavir, which inhibits HIV at multiple stages, recently showed promising results in prevention trials.
|
||||
|
|
||||
You Might Like |
||||
